102 related articles for article (PubMed ID: 2641014)
1. Demographic, behavioral and clinical features of HIV infection in NYC intravenous drug abusers.
Brown LS; Chu A; Nemoto T; Primm BJ
NIDA Res Monogr; 1989; 95():413-4. PubMed ID: 2641014
[No Abstract] [Full Text] [Related]
2. Prospective study of HIV infection among parenteral drug abusers.
Cushman P; Escobar M
J Subst Abuse; 1989; 1(4):461-5. PubMed ID: 2485291
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus and viral hepatitis seroepidemiology in New York City intravenous drug abusers (IVDAs).
Brown LS; Kreek MJ; Trepo C; Chu A; Banks SE; Valdes M; Ajuluchukwu D; Phillips R; Primm BJ
NIDA Res Monogr; 1989; 95():443-4. PubMed ID: 2641023
[No Abstract] [Full Text] [Related]
4. HIV infection in intravenous drug abusers (IVDAs) in NYC drug treatment clinics: 1985-1989.
Brown LS; Phillips RY; Nurco D; Primm B; Battjes R; Nemoto T
NIDA Res Monogr; 1990; 105():478-9. PubMed ID: 1876089
[No Abstract] [Full Text] [Related]
5. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
[TBL] [Abstract][Full Text] [Related]
6. HIV infection in drug abusers: research implications of descriptive studies.
Dorus W; Schaefer M; Pachucki CT; Schaaff DM; Lentino JR
NIDA Res Monogr; 1991; 109():101-13. PubMed ID: 1753987
[No Abstract] [Full Text] [Related]
7. Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004.
Nguyen TQ; Gwynn RC; Kellerman SE; Begier E; Garg RK; Pfeiffer MR; Konty KJ; Torian L; Frieden TR; Thorpe LE
AIDS; 2008 Jan; 22(2):281-7. PubMed ID: 18097231
[TBL] [Abstract][Full Text] [Related]
8. Intravenous heroin use: its association with HIV infection in patients in methadone treatment.
Chu A; Brown LS; Banks S; Nemoto T; Primm BJ
NIDA Res Monogr; 1989; 95():447-8. PubMed ID: 2641025
[No Abstract] [Full Text] [Related]
9. [Do we need a methadone maintenance program?].
Täschner KL
Nervenarzt; 1991 Sep; 62(9):524-8. PubMed ID: 1956471
[No Abstract] [Full Text] [Related]
10. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
11. [The behavioral risk factors for contracting HIV infection in the intravenous administration of narcotics in abusers of psychoactive substances in the city of Rostov-on-Don].
Saukhat SR; Tormozova NM; Rabinovich VD; Orlov NV; Pankova AA; Vorontsov DV; Ryndich IV
Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):97-8. PubMed ID: 10096224
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of HIV antibodies in intravenous drug-dependent patients 1986 and 1987 in Vienna].
Pakesch G; Presslich O; Willinger G; Loimer N; Fodor G; Müller K; Lieber A
Wien Klin Wochenschr; 1987 Nov; 99(22):777-80. PubMed ID: 3501637
[TBL] [Abstract][Full Text] [Related]
14. Acquired immunodeficiency syndrome among adolescents. Case surveillance profiles in New York City and the rest of the United States.
Vermund SH; Hein K; Gayle HD; Cary JM; Thomas PA; Drucker E
Am J Dis Child; 1989 Oct; 143(10):1220-5. PubMed ID: 2801666
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial risk factors for HIV transmission in male drug abusers.
Brook JS; Brook DW; Whiteman M; Roberto J; Masci JR; De Catalogne J; Amundsen F
Genet Soc Gen Psychol Monogr; 1993 Aug; 119(3):369-87. PubMed ID: 8243990
[TBL] [Abstract][Full Text] [Related]
16. [The risk factors for the transmission of HIV infection among intravenous narcotic users in Russia].
Savchenko IG; Pokrovskiĭ VV; Briun EA
Vopr Virusol; 1993; 38(6):258-61. PubMed ID: 8303885
[TBL] [Abstract][Full Text] [Related]
17. [HIV infection in intravenous drug dependent patients--Vienna 1988 results].
Loimer N; Presslich O; Hollerer E; Pfersmann V; Pakesch G; Pfersmann D
Wien Med Wochenschr; 1989 Jul; 139(14):334-6. PubMed ID: 2788964
[TBL] [Abstract][Full Text] [Related]
18. Scale-up of opioid substitution therapy in India: opportunities and challenges.
Kumar MS; Agrawal A
Int J Drug Policy; 2012 Mar; 23(2):169-70. PubMed ID: 22280919
[No Abstract] [Full Text] [Related]
19. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
[No Abstract] [Full Text] [Related]
20. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
